FDA urges risk management plans for drug shortages
The U.S. Food and Drug Administration (FDA) is calling on drug manufacturer...Read more on AuntMinnie.comRelated Reading: Brigham and Women's gets FDA warning letter on PET tracers FDA clears modification for XACT's ablation steering system FDA OKs new AI-based breast, prostate cancer tools from RadNet FDA grants approval for diagnostic test for Alzheimer's plaques FDA doubles MRI scans needed for Aduhelm patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 20, 2022 Category: Radiology Source Type: news

Prostate Cancer Survival: Enzalutamide Edges Out Abiraterone Prostate Cancer Survival: Enzalutamide Edges Out Abiraterone
Men with metastatic disease who received enzalutamide demonstrated a small but significant survival benefit. The study was published as a preprint and has not yet been peer reviewed.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 20, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

PET/MRI provides new insights into knee osteoarthritis
PET/MRI has identified which compartments of the knee may be the best target...Read more on AuntMinnie.comRelated Reading: PET/MRI superior to MRI for diagnosing prostate cancer ECR: Hypmed project develops affordable PET/MRI for breast scans PET/MRI appears safe for pregnant women PET/MRI can improve diagnosis of peritoneal cancer PET/MRI proves TNF blockers effective for ankylosing spondylitis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 19, 2022 Category: Radiology Source Type: news

Checks for prostate cancer hit all-time high
Record numbers of men are getting checked for prostate cancer thanks to a lifesaving awareness raising campaign. (Source: NHS Networks)
Source: NHS Networks - May 19, 2022 Category: UK Health Source Type: news

Just How Effective Is PSA Screening?
(MedPage Today) -- NEW ORLEANS -- Prostate cancer screening with prostate-specific antigen (PSA) blood testing appears to have a more favorable benefit-to-harm trade-off than originally estimated, particularly among Black men, according to research... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 18, 2022 Category: Hematology Source Type: news

MRI radiomics heralds a paradigm shift in brain imaging
MRI radiomics could have a tremendous impact on the lives of patients with brai...Read more on AuntMinnie.comRelated Reading: MRI radiomics identifies subtypes of inflammatory bowel disease MRI radiomics help predict prostate cancer metastases MRI radiomics can help predict breast cancer treatment response AI, radiomics can predict cancer in lesions found on breast MRI MRI radiomics can predict risk of breast cancer recurrence (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 18, 2022 Category: Radiology Source Type: news

Mental Health Issues Common, Often Overlooked in Prostate Cancer
(MedPage Today) -- NEW ORLEANS -- More than a third of men with newly diagnosed prostate cancer had at least one mental health issue, which had a strong association with prior psychological wellbeing, a prospective cohort study showed. Almost... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - May 17, 2022 Category: Psychiatry Source Type: news

Prostate cancer screening is better than originally thought, especially for Black men, study says
A blood test to screen for prostate cancer may be better at doing so than experts originally thought, particularly among Black men, according to a new study. (Source: CNN.com - Health)
Source: CNN.com - Health - May 17, 2022 Category: Consumer Health News Source Type: news

AUA: Pandemic Disruptions Impacted One in Four Prostate, Bladder Cancer Patients
MONDAY, May 16, 2022 -- Approximately one-quarter of prostate cancer and bladder cancer patients requiring treatment or other ancillary care during the pandemic reported change, delay, or cancellation of care, according to a study presented at the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2022 Category: Pharmaceuticals Source Type: news

FDA OKs new AI-based breast, prostate cancer tools from RadNet
The U.S. Food and Drug Administration (FDA) has given 510(k) clearance to artificia...Read more on AuntMinnie.comRelated Reading: RadNet reports revenue increases for Q1 RadNet broadens AI focus with acquisitions of Aidence, Quantib RadNet reports increase in revenue in Q3 RadNet shows recovery from pandemic impact in Q3 RadNet, Hologic to collaborate on breast health AI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 16, 2022 Category: Radiology Source Type: news

FDA OKs new AI-based breast, prostate cancer tools
The U.S. Food and Drug Administration (FDA) has given 510(k) clearance to artificia...Read more on AuntMinnie.comRelated Reading: RadNet reports revenue increases for Q1 RadNet broadens AI focus with acquisitions of Aidence, Quantib RadNet reports increase in revenue in Q3 RadNet shows recovery from pandemic impact in Q3 RadNet, Hologic to collaborate on breast health AI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 16, 2022 Category: Radiology Source Type: news

Prostate cancer: How do you 'feel' after going to the toilet? Doctor warns of early sign
PROSTATE cancer is the third biggest cancer killer in the UK, with one man dying every 45 minutes from the disease. As part of a campaign to get more men tested for the deadly disease, Doctor Jiri Kubes of Proton Therapy Center outlined the initial warning signs, which include a particular feeling after going to the toilet. (Source: Daily Express - Health)
Source: Daily Express - Health - May 16, 2022 Category: Consumer Health News Source Type: news

Most Men With Low-Risk Prostate Tumors Now Forgoing Treatment Most Men With Low-Risk Prostate Tumors Now Forgoing Treatment
Acceptance of active surveillance for low-risk prostate cancer hit a record high in 2021, although the US still lags internationally, new figures showed.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 15, 2022 Category: Cancer & Oncology Tags: Urology News Source Type: news

Cancer: New drug that can ‘double’ life expectancy approved on the NHS
LUNG cancer is one of the four most common cancers in the UK alongside breast, bowel, and prostate cancer. It is also a cancer with one of the lowest survival rates in the UK. However, in a boost to patients, a new drug capable of doubling life expectancy has been approved for use on the NHS. (Source: Daily Express - Health)
Source: Daily Express - Health - May 14, 2022 Category: Consumer Health News Source Type: news

MRI radiomics identifies subtypes of inflammatory bowel disease
MRI radiomics and machine learning can enable identification of inflammator...Read more on AuntMinnie.comRelated Reading: MRI radiomics help predict prostate cancer metastases Radiomics, AI primed for bigger role in genitourinary applications CT radiomics predicts rectal cancer treatment response Ultrasound predicts ulcerative colitis treatment response Cinematic rendering complements CT in diagnosing colitis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 13, 2022 Category: Radiology Source Type: news